Hemispherx BioPharma (NYSEAMERICAN:HEB) Executives Voluntarily Forgo 2024 Cash Bonuses
On December 19, 2024, Hemispherx BioPharma (NYSEAMERICAN:HEB) disclosed in an 8-K filing that executives Thomas K. Equels and Peter W. Rodino III have voluntarily decided to waive their entitlement to cash bonuses for the year 2024. This decision was communicated to the Compensation Committee of the Company’s Board of Directors as a means to assist […]
More Stories
Short Interest in Bouygues SA (OTCMKTS:BOUYY) Drops By 77.4%
Bouygues SA (OTCMKTS:BOUYY – Get Free Report) was the target of a significant drop in short interest in December. As...
WEED, Inc. (OTCMKTS:BUDZ) Short Interest Update
WEED, Inc. (OTCMKTS:BUDZ – Get Free Report) was the target of a large drop in short interest in December. As...
FIBRA Terrafina (OTCMKTS:CBAOF) Short Interest Down 65.9% in December
FIBRA Terrafina (OTCMKTS:CBAOF – Get Free Report) was the recipient of a significant decrease in short interest during the month...
Analyzing Rectitude (NASDAQ:RECT) and Eastern (NASDAQ:EML)
Institutional & Insider Ownership 77.0% of Eastern shares are owned by institutional investors. 17.0% of Eastern shares are owned by...
Pacer Nasdaq International Patent Leaders ETF Plans Dividend of $0.06 (NASDAQ:PATN)
Pacer Nasdaq International Patent Leaders ETF (NASDAQ:PATN – Get Free Report) announced a dividend on Thursday, December 26th,NASDAQ Dividends reports....
B3 S.A. – Brasil, Bolsa, Balcão to Issue Dividend of $0.02 (OTC:BOLSY)
B3 S.A. – Brasil, Bolsa, Balcão (OTC:BOLSY – Get Free Report) declared a dividend on Thursday, December 26th,NASDAQ Dividends reports....